Standout Papers
- Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group (2012)
- Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study (2008)
- Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031 (2014)
Immediate Impact
3 by Nobel laureates 19 from Science/Nature 68 standout
Citing Papers
Management of ALL in adults: 2024 ELN recommendations from a European expert panel
2024 Standout
Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia
2023 Standout
Works of Naomi Winick being referenced
FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children’s Oncology Group trial AALL0631
2021
Intensified chemotherapy without SCT in infant ALL: Results from COG P9407 (Cohort 3)
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Naomi Winick | 6089 | 4269 | 3317 | 238 | 9.3k | |
| Paul S. Gaynon | 8367 | 5037 | 5029 | 191 | 11.2k | |
| Sima Jeha | 4612 | 3029 | 3349 | 220 | 8.8k | |
| Meenakshi Devidas | 7742 | 5307 | 4394 | 307 | 12.1k | |
| Bruce M. Camitta | 6728 | 4144 | 6693 | 214 | 12.3k | |
| John T. Sandlund | 5616 | 3879 | 3345 | 168 | 10.2k | |
| Kjeld Schmiegelow | 7517 | 6098 | 2569 | 475 | 12.6k | |
| Peter G. Steinherz | 3982 | 2161 | 3419 | 166 | 7.3k | |
| Beverly J. Lange | 4505 | 2570 | 4954 | 211 | 11.3k | |
| Giuseppe Masera | 3826 | 2995 | 2956 | 236 | 7.1k | |
| Marry M. van den Heuvel‐Eibrink | 3225 | 3760 | 2226 | 438 | 10.7k |
All Works
Login with ORCID to disown or claim papers
Loading papers...